Is PAIOF or GBDC a better dividend investment in 2026?

PAIOF currently yields 20000.00% with a 5% 5-year dividend growth rate. GBDC yields 11.86% with 5% growth. The better choice depends on your goal: PAIOF offers higher current income.

What is the dividend yield difference between PAIOF and GBDC?

PAIOF has a forward dividend yield of 20000.00% ($2.00/share annually). GBDC yields 11.86% ($1.50/share annually). The yield gap is 19988.14 percentage points.

Home › Compare › PAIOF vs GBDC

PAIOF vs GBDC: Dividend Comparison 2026

PAIOF yields 20000.00% · GBDC yields 11.86%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PAIOF wins by $52481917574412746752.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

PAIOF

● Live price

20000.00%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$52481917574412746752.00M

Annual income

$51,970,745,957,167,775,000,000,000.00

Full PAIOF calculator →

GBDC

● Live price

11.86%

Share price

$12.65

Annual div

$1.50

5Y div CAGR

51.1%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.85M

Annual income

$16,450,733.83

Full GBDC calculator →

Portfolio growth — PAIOF vs GBDC

📍 PAIOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PAIOF	GBDC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PAIOF + GBDC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PAIOF pays

GBDC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PAIOF

Annual income on $10K today (after 15% tax)

$1,700,000.00/yr

After 10yr DRIP, annual income (after tax)

$44,175,134,063,592,610,000,000,000.00/yr

GBDC

Annual income on $10K today (after 15% tax)

$1,007.91/yr

After 10yr DRIP, annual income (after tax)

$13,983,123.76/yr

At 15% tax rate, PAIOF beats the other by $44,175,134,063,592,610,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PAIOF + GBDC for your $10,000?

PAIOF: 50%GBDC: 50%

100% GBDC50/50100% PAIOF

Portfolio after 10yr

$26240958787206373376.00M

Annual income

$25,985,372,978,583,888,000,000,000.00/yr

Blended yield

99.03%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

PAIOF

No analyst data

Altman Z

-10.7

Piotroski

3/9

GBDC

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$14.00

+10.7% upside vs current

Range: $13.00 — $15.00

Altman Z

0.6

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PAIOF buys

GBDC buys

No recent congressional trades found for PAIOF or GBDC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPAIOFGBDC

Forward yield	20000.00% ✓	11.86%
Annual dividend / share	$2.00 ✓	$1.50
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	51.1% ✓
Portfolio after 10y	$52481917574412746752.00M ✓	$20.85M
Annual income after 10y	$51,970,745,957,167,775,000,000,000.00 ✓	$16,450,733.83
Total dividends collected	$52448189483771600896.00M ✓	$20.43M
Payment frequency	quarterly	quarterly
Sector	Stock	BDC

Year-by-year: PAIOF vs GBDC ($10,000, DRIP)

Year	PAIOF Portfolio	PAIOF Income/yr	GBDC Portfolio	GBDC Income/yr	Gap
1← crossover	$2,010,700	$2,000,000.00	$12,492	$1,791.70	+$2.00M → PAIOF
2	$377,983,225	$375,831,775.70	$16,527	$3,160.58	+$377.97M → PAIOF
3	$66,433,479,469	$66,029,037,418.28	$23,588	$5,904.90	+$66433.46M → PAIOF
4	$10,916,985,471,987	$10,845,901,648,955.73	$37,141	$11,901.65	+$10916985.43M → PAIOF
5	$1,677,384,363,769,318	$1,665,703,189,314,291.80	$66,205	$26,463.38	+$1677384363.70M → PAIOF
6	$240,985,175,079,139,100	$239,190,373,809,905,920.00	$137,452	$66,612.65	+$240985175079.00M → PAIOF
7	$32,373,573,631,143,694,000	$32,115,719,493,809,017,000.00	$342,372	$195,298.53	+$32373573631143.35M → PAIOF
8	$4,066,766,648,320,630,000,000	$4,032,126,924,535,306,000,000.00	$1,053,292	$686,954.33	+$4066766648320629.00M → PAIOF
9	$477,730,483,406,513,300,000,000	$473,379,043,092,810,300,000,000.00	$4,111,439	$2,984,416.95	+$477730483406513344.00M → PAIOF
10	$52,481,917,574,412,750,000,000,000	$51,970,745,957,167,775,000,000,000.00	$20,849,974	$16,450,733.83	+$52481917574412746752.00M → PAIOF

PAIOF vs GBDC: Complete Analysis 2026

PAIOF — Stock

Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and critical care services worldwide. The company's lead product is Remimazolam, an ultra-short-acting intravenous benzodiazepine sedative/anesthetic, which is in clinical development for use in procedural sedation, general anesthesia, and intensive care unit sedation. It is also developing Angiotensin II, a vasoconstrictor indicated for the treatment of refractory hypotension in adults with septic or other distributive shock; and Eravacycline, a novel fluorocycline antibiotic indicated for the treatment of complicated intra-abdominal infections in adults. The company has partnerships and license agreements with Cosmo Pharmaceuticals, Wuhan Humanwell Innovative Drug Research and Development Center Limited Company, Hana Pharm, Yichang Humanwell, and Mundipharma. Paion AG was founded in 2000 and is based in Aachen, Germany.

Full PAIOF Calculator →

GBDC — BDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →

📬

Get this PAIOF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PAIOF vs SCHD PAIOF vs JEPI PAIOF vs O PAIOF vs KO PAIOF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.